On the contrary, the count of Ki‐67‐positive cells was increased in three EPO‐MSCs treatment groups, especially in D1 and D1 + 7 groups than in BPD group (P < 0.05, Figure 2C,D). Here, MKI67 is linked to bronchopulmonary dysplasia.